The Cell Saga isn't the most flawed arc between the original anime and DBZ, but it has the worst balance between its strengths and weaknesses. Many Dragon Ball Z fans cite the Cell Saga as their ...

ARC101 is the company’s first bispecific antibody targeting Claudin 6 (CLDN6), optimized for best-in-class T cell engagement — First-in-human study will evaluate the safety, tolerability, ...

This week's round-up of new financings in the biotech world is headed by a big round for Third Arc, a specialist in T-cell engager antibodies, with Autobahn, Brenig, Confo, and GRO Bio also in on ...

-- ARC101 is the company's first bispecific antibody targeting Claudin 6 (CLDN6), optimized for best-in-class T cell engagement -- First-in-human study will evaluate the safety, tolerability ...

Frances Arnold, PhD (Nobel Prize Lecture 2018) In a new preprint that is not yet peer-reviewed and first published on Arc’s website, Evo 2 moves beyond single-cell genomes of bacteria and ...

ARC101 is the company's first bispecific antibody targeting Claudin 6 (CLDN6), optimized for best-in-class T cell engagement SPRING HOUSE, Pa., March 13, 2025 /PRNewswire/ -- Third Arc Bio Inc., ...